Supply Watch

The UK parallel export restriction list, and the two latest additions

11 September 2026

The UK government publishes a list of medicines that cannot be exported from the UK or hoarded. GOV.UK describes it as covering medicines needed for UK patients. The Department of Health and Social Care and the MHRA publish it, and the page was last updated on 9 September 2026.

What the list is

The list is a table with four columns, covering medicine name, strength, pharmaceutical form and date of restriction. An entry can be narrow, such as a single strength and form, or broad, such as all strengths in all forms. The restrictions follow the medicine name in the NHS dictionary of medicines and devices, and GOV.UK says they sit on the virtual therapeutic moiety unless a specific product is listed.

GOV.UK states that hoarding or exporting a listed medicine is a breach of regulation 43(2) of the Human Medicines Regulations 2012 and a contravention of the wholesale dealer licence. It adds that this may lead to regulatory action by the MHRA, which could include immediate suspension of the licence. Questions go to restrictedmedicines@dhsc.gov.uk.

The list moves in both directions. The 10 July 2026 update removed glucagon and terbutaline injection, and the 25 March 2026 update added and removed several products together.

The two latest additions

Ramipril, all strengths and all forms, has a restriction date of 8 August 2026. GOV.UK logged it in the 7 August update. We reported the supply position for the capsules in our ramipril note.

Raltitrexed, all strengths and all forms, was added in the 9 September 2026 update, with a restriction date of 10 September 2026.

In both cases the restriction date falls one day after the update date on the page. GOV.UK's earlier entries describe the date of restriction as 00:00 at the start of the day after the update.

What it means for supply

The list restricts where stock can go. It is not a shortage notice, but a new entry tells you DHSC wants that medicine kept in the UK supply chain. Ramipril shows how that can run ahead of a shortage widening. It was restricted on 8 August, a month before the 7 September notification extended the shortage to all four capsule strengths.

The current list is the CSV attached to the GOV.UK publication page.

Written by the AIWAS Medical trade desk. Market commentary for pharmacy professionals, not official guidance and not an offer to supply.